Phytochemical, Antioxidant and Antibacterial Evaluation of Aerial-Part Extracts of Tanacetum parthenium L.
Keywords:
Tanacetum parthenium, aerial-part extract, phytochemical screening, antioxidant activity, antibacterial activityAbstract
Background: Tanacetum parthenium L., often known as feverfew, is a medicinal plant that has long been used to prevent migraines and treat inflammatory diseases. Nevertheless, there is still a lack of comparative information about the phytochemical and biological characteristics of its aerial-part extracts. The purpose of this research was to assess the phytochemical components, antibacterial potential, and antioxidant activity of petroleum ether, ethanol, and aqueous extracts of T. parthenium aerial parts. Methods: The extracts were submitted to qualitative phytochemical screening after successive solvent extraction. Folin-Ciocalteu and aluminum chloride techniques were used to measure the total phenolic content (TPC) and total flavonoid content (TFC), respectively. The DPPH radical-scavenging test was used to measure antioxidant activity, while broth microdilution and agar well diffusion methods were used to measure antibacterial activity against Staphylococcus aureus, Bacillus subtilis, Escherichia coli, and Pseudomonas aeruginosa. Findings: The ethanol extract had the strongest DPPH scavenging activity (IC50 52.31 ± 1.49 µg/mL) and the greatest TPC (148.72 ± 3.15 mg GAE/g) and TFC (62.34 ± 1.92 mg QE/g). Additionally, it showed the biggest zones of inhibition, and the most vulnerable organism was S. aureus (19.4 ± 0.8 mm; MIC 1.56 mg/mL). While the petroleum ether extract was essentially inert, the aqueous extract exhibited modest activity. In conclusion, the ethanol extract of the aerial portions of T. parthenium is a rich source of phenolic compounds with notable antibacterial and antioxidant properties in vitro, indicating the need for more research to isolate bioactive components and assess safety.
References
World Health Organization. WHO traditional medicine strategy: 2014-2023. Geneva: WHO Press; 2013.
Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014;4:177.
Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Environ Health Perspect. 2001;109(Suppl 1):69-75.
Rates SMK. Plants as source of drugs. Toxicon. 2001;39(5):603-613.
Bourgaud F, Gravot A, Milesi S, Gontier E. Production of plant secondary metabolites: a historical perspective. Plant Sci. 2001;161(5):839-851.
Scalbert A, Johnson IT, Saltmarsh M. Polyphenols: antioxidants and beyond. Am J Clin Nutr. 2005;81(1 Suppl):215S-217S.
Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev. 1999;12(4):564-582.
Krishnaiah D, Sarbatly R, Nithyanandam R. A review of the antioxidant potential of medicinal plant species. Food Bioprod Process. 2011;89(3):217-233.
Harborne JB. Phytochemical methods: a guide to modern techniques of plant analysis. 3rd ed. London: Chapman and Hall; 1998.
Mabberley DJ. Mabberley’s plant-book: a portable dictionary of plants, their classification and uses. 4th ed. Cambridge: Cambridge University Press; 2017.
Pareek A, Suthar M, Rathore GS, Bansal V. Feverfew (Tanacetum parthenium L.): a systematic review. Pharmacogn Rev. 2011;5(9):103-110.
Tutin TG, Heywood VH, Burges NA, et al., editors. Flora Europaea. Vol 4. Cambridge: Cambridge University Press; 1976.
Ernst E, Pittler MH. The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review. Public Health Nutr. 2000;3(4A):509-514.
Awang DVC. Feverfew: a review of its history, its biological and medicinal properties, and the status of commercial preparations. HerbalGram. 1993;(29):34-43.
Heptinstall S, Awang DVC, Dawson BA, et al. Parthenolide content and bioactivity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.). Estimation of commercial and authenticated feverfew products. J Pharm Pharmacol. 1992;44(5):391-395.
Johnson ES, Kadam NP, Hylands DM, Hylands PJ. Efficacy of feverfew as prophylactic treatment of migraine. Br Med J (Clin Res Ed). 1985;291(6495):569-573.
Williams CA, Harborne JB, Geiger H, Hoult JRS. The flavonoids of Tanacetum parthenium and T. vulgare and their anti-inflammatory properties. Phytochemistry. 1999;51(3):417-423.
Mojab F, Javidnia K, Yazdani D, et al. Antibacterial activity of Tanacetum parthenium essential oil. J Essent Oil Bear Plants. 2009;12(5):571-576.
British Herbal Medicine Association. British Herbal Pharmacopoeia. 4th ed. Bournemouth: BHMA; 1996.
European Medicines Agency. Assessment report on Tanacetum parthenium (L.) Schultz Bip., herba. London: EMA; 2011. Doc. Ref. EMA/HMPC/48716/2010.
Wu C, Chen F, Wang X, et al. Antioxidant constituents in feverfew (Tanacetum parthenium) extract and their chromatographic quantification. Food Chem. 2006;96(2):220-227.
Marles RJ, Kaminski J, Arnason JT, et al. A bioassay-guided fractionation of feverfew extracts for insect antifeedant activity. J Econ Entomol. 1992;85(5):1736-1741.
Lahlou M. The success of natural products in drug discovery. Pharmacol Pharm. 2013;4(3A):17-31.
Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015;40(4):277-283.
Gibbons S. Anti-staphylococcal plant natural products. Nat Prod Rep. 2004;21(2):263-277.
Singleton VL, Orthofer R, Lamuela-Raventós RM. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Methods Enzymol. 1999;299:152-178.
Prieto P, Pineda M, Aguilar M. Spectrophotometric quantitation of antioxidant capacity through the formation of a phosphomolybdenum complex: specific application to the determination of vitamin E. Anal Biochem. 1999;269(2):337-341.
Eloff JN. A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Med. 1998;64(8):711-713.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2026 Kavya Setu

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.